Longevity
Epithalon Benefits: Telomeres, Hype, and Reality
Interesting cell data, a possible sleep effect, and an unproven aging claim.
The quick version
- A longevity peptide tied to telomeres and sleep.
- Lengthens telomeres in cells; the human longevity benefit is unproven.
- People run short pulses, about 5 to 10 mg a day, a couple times a year.
What it is
Epithalon is a four-part peptide from Russian research, tied to the pineal gland and sleep. It is best known for the claim that it lengthens telomeres, the caps on your DNA that shorten with age.
What the research shows
In lab dishes, epithalon can switch on telomerase and lengthen telomeres in human cells, including in a 2025 study (Brunel et al., 2025). The weak spot is people. The human studies are small, old, mostly Russian, and lack the strong designs Western regulators expect. There are no validated markers showing it adds healthy years. Cell data, yes, human proof, no.
What it felt like
I have run a short epithalon course mainly for sleep. I did fall asleep faster for a week or two, which lines up with its pineal link, but I cannot say anything about aging from my own use, and no one really can.
Dosing reality
Protocols people share run about 5 to 10 mg per day in short courses a couple of times a year. These are anecdotal patterns, not label doses, since it is unapproved.
The one mistake to avoid
The mistake is buying the longevity promise. Treat any anti-aging claim as unproven, and judge it on something you can feel, like sleep, over a short trial.
Bottom line
Epithalon has interesting cell data and a possible sleep effect, but the longevity story is unproven in people. Keep expectations low.
Reminder: I am not a doctor and this is not medical advice. It is my own notes and reading of the research. Peptides sit in a legal grey area, research-grade is a real category, and it is on you to verify your own compliance. Talk to a qualified professional before you start anything, especially if you take other medication.